Where does Sanofi-Aventis Deutschland GMBH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Sanofi-Aventis Deutschland GMBH ranks #320 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Sanofi-Aventis Deutschland GMBH hold?

Sanofi-Aventis Deutschland GMBH holds 1,348 US utility patents granted between 2015 and 2025, spanning 89 technology areas.

What is Sanofi-Aventis Deutschland GMBH's Innovation Score?

Sanofi-Aventis Deutschland GMBH has an Innovation Score of 63.4 out of 100 (top 2% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Sanofi-Aventis Deutschland GMBH's patent grant rate increasing or decreasing?

Sanofi-Aventis Deutschland GMBH's recent grant velocity is -43% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Sanofi-Aventis Deutschland GMBH's patents?

Sanofi-Aventis Deutschland GMBH's patents average 16.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Sanofi-Aventis Deutschland GMBH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sanofi-Aventis Deutschland GMBH

Q: What technology areas does Sanofi-Aventis Deutschland GMBH focus on?

Sanofi-Aventis Deutschland GMBH's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 1,159 patents, ranking #2 of 3,490 assignees active in that subclass. Grants appear in 89 CPC subclasses total.

USPTO PatentsView assignee record - 1,348 granted patents across 89 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Sanofi-aventis ranks #320 of 49,997 tracked US assignees by granted-patent volume, with 1,348 patents across 89 technology areas.

#320
of 49,997 US assignees by volume: Top 2%
by Innovation Score (63.4/100): 16.3
avg claims per patent: -43%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R320 · Foreign Corporation #320 · 1,348 grants

GRANTS-LARGE · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-LARGE 1.3K grants
TOP-DECILE #320/49,997
PHOTO-FINISH Beijing Bytedance…
CPC-WIDE A61M · 89 areas
INNOV-STRONG 63.4/100
CLAIMS-RICH 16.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -43% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Beijing Bytedance Network Technology Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Sanofi-aventis’s 63.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 24.9 pts (39%) Velocity 3.7 pts (6%) Breadth 25.0 pts (39%) Claim depth 9.8 pts (15%)

Qualcomm Incorporated · highest

85
3D Systems · near

63
Carl Zeiss Microscopy · near

63
Sanofi-Aventis… · this assignee

63
Terumo · near

63
United · near

63
3D Lighting… · lowest

7

What this shows Sanofi-aventis's Innovation Score is 63.4/100 (top 2% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Sanofi-aventis?

Each dot is one of Sanofi-aventis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sanofi-aventis’s own 16.3 claims/patent is ABOVE the 12.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Sanofi-aventis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Sanofi-aventis's grant cadence moved

Between 2020–2024, Sanofi-Aventis Deutschland GMBH received 459 grants versus 802 in 2015–2019 (-43% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2016 at 217 grants and bottomed in 2023 at 65. Lead class A61M accounts for 86% of the portfolio across 89 subclasses. Volume neighbours: Delta Faucet Company (#316) and Avago Technologies General IP (Singapore) Pte. Ltd. (#324).

Sanofi-aventis's three-year grant acceleration

From 2019–2021 to 2022–2024, Sanofi-Aventis Deutschland GMBH moved from 401 to 225 grants (0.56x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,543. See the growth leaderboard.

Delta Faucet

1,351
Acer Incorporated

1,350
Exxonmobil Chemic…

1,350
Beijing Bytedance…

1,348
Sanofi-aventis De… ◀

1,348
Harman Internatio…

1,341
Kubota

1,340
Cook Medical

1,327
Avago General IP…

1,321

What this shows Sanofi-Aventis holds 1,348 patents at rank #320, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sanofi-Aventis

By rank, the assignees closest to #320 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Sanofi-Aventis's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Sanofi-Aventis, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Sanofi-Aventis ranks #2 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (63 here).

Terumo Kabushiki Kaisha 63 United Technologies Corporation 63 Carl Zeiss Microscopy GmbH 63 3D Systems, Inc. 63

Similar claim depth

Nearest assignees by average claims per patent (16.3 here).

Rockwell Collins, Inc. 16.3 avg Lite-on Opto Technology (CHANGZHOU) Co., Ltd. 16.3 avg Julius-Maximilians-Universitat Wurzburg 16.3 avg Alcatel Lucent 16.3 avg

Sanofi-aventis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

63 Top 2% higher than 98% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Sanofi-Aventis Deutschland GMBH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	121	9.0%
2016	217	16.1%
2017	184	13.6%
2018	113	8.4%
2019	167	12.4%
2020	126	9.3%
2021	108	8.0%
2022	94	7.0%
2023	65	4.8%
2024	66	4.9%
2025partial year	87	6.5%

Which technologies does Sanofi-Aventis Deutschland GMBH patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1,159

Y10T - Technical Subjects Covered BY Former US Classification 99

A61B - DIAGNOSIS; SURGERY; Identification 85

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 79

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 55

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 38

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 37

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 30

G01D - Measuring NOT Specially Adapted FOR A Specific VARIABLE; Arrangements FOR Measuring TWO OR More Variables NOT Covered IN A Single Other SUBCLASS; Tariff Metering APPARATUS; Measuring OR Testing NOT Otherwise Provided FOR 27

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 27

G01F - Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume 20

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 19

F16H - Gearing 16

G06V - Image OR Video Recognition OR Understanding 15

C07K - Peptides 15

Top 15 of 89 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Sanofi-Aventis Deutschland GMBH's patent record in context - here's where to go next.

Sanofi-Aventis Deutschland GMBH's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 86% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #320 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Sanofi-Aventis Deutschland GMBH against Delta Faucet Company, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 63.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.